REFERENCES
- Criner G J, Sharafkhaneh A, Player R, et al. Efficacy of tiotropium inhalation powder in African American patients with chronic obstructive pulmonary disease. J COPD 2007, this issue
- Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. MMWR Surveill Summ 2002; 51: SS–6
- Chatila W M, Hoffman E A, Gaughan J, Robinswood G B, Criner G J, for the National Emphysema Treatment Trial Research Group. Advanced emphysema in African American and white patients: Do differences exist?. Chest 2006; 130: 108–118
- Chatila W M, Wynkoop W A, Vance G, Criner G J. Smoking patterns in African Americans and whites with advanced COPD. Chest 2004; 125: 15–21
- Dransfield M T, Davis J J, Gerald L B, Bailey W C. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Resp Med 2006; 100: 1110–1116
- Ferdinand K C. Recommendations for the management of special populations: racial and ethnic populations. Am J Hypertens 2003; 16: 50S–54S
- Exner D V, Dries D L, Domanski M J, Cohn J N. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344: 1351–1357
- Carson P, Ziesche S, Johnson G, Cohn J N, for the Vasodilator-Heart Failure Trial Study Group. Racial differences in response to therapy for heart failure: analysis of the vaso-dilator-heart failure trials. J Card Fail 1999; 5: 178–187
- Nelson H S, Weiss S T, Bleeker E R, Yancey S W, Dorinsky P M, the SMART Study Group. The salmeterol multicenter asthma research trial, a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 126: 15–26
- Israel E, Drazen J M, Liggett S B, Boushey H A, Cherniack R M, Chinchilli V M, Cooper D M, Fahy J V, Fish J E, Ford J G, Kraft M, Kunselman S, Lazarus S C, Lemanske R F, Jr, Martin R J, McLean D, Peters S P, Silverman E K, Sorkness C A, Szefler S J, Weiss S T, Yandava C N, for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. The effect of polymorphisms of the β2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162: 75–80
- Israel E, Chinchilli V M, Ford J G, Boushey H A, Cherniack R, Craig T J, Deykin A, Fagan J K, Fahy J V, Fish J, Kraft M, Kunselman S J, Lazarus S C, Lemanske R F, Jr, Liggett S B, Martin R J, Mitra N, Peters S P, Silverman E, Sorkness C A, Szefler S J, Wechsler M E, Weiss S T, Drazen J M, for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled, cross-over trial. Lancet 2004; 364: 1505–1512
- Casaburi R, Mahler D A, Jones P W, Wanner A, San Pedro G, ZuWallack R L, Menjoge S S, Serby C W, Witek T J. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217–224
- Federico M J, Covar R A, Brown E E, et al. Racial differences in T-lymphocyte response to glucocorticoids. Chest 2005; 127: 571–578
- Niewoehner R, Rice K, Cote C, Korducki L, Cassino C, Kesten S. Characteristics of COPD and response to once daily tiotropium in African Americans in the VA medical system. Proc American Thorac Soc 2005; 2: A543
- Johnson J A, Burlew B S, Siles R N. Racial differences in β -adrenoreceptor-mediated responsiveness. J Cardiovasc Pharmacol 1995; 25: 90–96
- Yoos H L, Kitzman H, McMullen A, et al. The language of breathlessness: do families and health care providers speak the same language when describing asthma symptoms?. J Pediatr Health Care 2005; 19: 197–205
- Hardie G E, Gold W M, Janson S, et al. Understanding how asthmatics perceive symptom distress during a methacholine challenge. J Asthma 2002; 39: 611–618
- Kifle Y, Seng V, Davenport P W. Magnitude estimation of inspiratory resistive loads in children with life-threatening asthma. Am J Respir Crit Care Med 1997; 156: 1530–1535
- Hardie G E, Janson S, Gold W M, Carrieri-Kohlman V, Boushey H A. Ethnic differences: word descriptors used by African-American and white asthma patients during induced bronchoconstriction. Chest 2000; 117: 935–943
- Dusser D, Bravo M L, Iacono P, on behalf of the Mistral study group. The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J 2006; 27: 547–555
- Dransfield M T, Bailey W C. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006; 27(3)463–471